Is It Possible To Improve The Prognostic Ability Of The Imdc Score? Validation Of The Meet-Uro Score In Metastatic Renal Cell Carcinoma (Mrcc) Patients (Pts) Receiving First-Line Nivolumab Plus Ipilimumab In The Italian Expanded Access Program (Eap)
ANNALS OF ONCOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要